Michiya Masue

627 total citations
20 papers, 520 citations indexed

About

Michiya Masue is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Michiya Masue has authored 20 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Michiya Masue's work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (10 papers), Lysosomal Storage Disorders Research (6 papers) and Trypanosoma species research and implications (5 papers). Michiya Masue is often cited by papers focused on Hyperglycemia and glycemic control in critically ill and hospitalized patients (10 papers), Lysosomal Storage Disorders Research (6 papers) and Trypanosoma species research and implications (5 papers). Michiya Masue collaborates with scholars based in Japan, United States and Iran. Michiya Masue's co-authors include Kazuko Sukegawa, Tadao Orii, Seiji Fukuda, Shunji Tomatsu, Yoshihiro Nakashima, Tohru Yorifuji, Hironori Nishibori, Takashi Hashimoto, Tatsuya Ogawa and Rie Kawakita and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Michiya Masue

19 papers receiving 510 citations

Peers

Michiya Masue
Celeste Decker United States
Susan J. Desnick United States
Radhika Narla United States
Eric P. Wartchow United States
Nora Watman Argentina
Michiya Masue
Citations per year, relative to Michiya Masue Michiya Masue (= 1×) peers Debora Karetová

Countries citing papers authored by Michiya Masue

Since Specialization
Citations

This map shows the geographic impact of Michiya Masue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiya Masue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiya Masue more than expected).

Fields of papers citing papers by Michiya Masue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiya Masue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiya Masue. The network helps show where Michiya Masue may publish in the future.

Co-authorship network of co-authors of Michiya Masue

This figure shows the co-authorship network connecting the top 25 collaborators of Michiya Masue. A scholar is included among the top collaborators of Michiya Masue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiya Masue. Michiya Masue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Takasawa, Kei, Yoko Saito, Nozomi Matsuda, et al.. (2024). Clinical management of diazoxide-unresponsive congenital hyperinsulinism: A single-center experience. Clinical Pediatric Endocrinology. 33(3). 187–194. 1 indexed citations
3.
Takahashi, Kazuhiro, et al.. (2019). Adjunctive kampo therapy for incomplete Kawasaki disease mimic associated with reaction at the bacillus Calmette–Guérin inoculation site. Traditional & Kampo Medicine. 6(1). 41–45. 1 indexed citations
4.
Kanamori, Yutaka, Toshihiko Watanabe, Tohru Yorifuji, et al.. (2018). Congenital hyperinsulinism treated by surgical resection of the hyperplastic lesion which had been preoperatively diagnosed by 18F-DOPA PET examination in Japan: a nationwide survey. Pediatric Surgery International. 34(10). 1093–1098. 4 indexed citations
6.
Hashimoto, Yukiko, Rie Kawakita, Yuki Hosokawa, et al.. (2015). Focal form of congenital hyperinsulinism clearly detectable by contrast-enhanced computed tomography imaging. International Journal of Pediatric Endocrinology. 2015(1). 20–20. 2 indexed citations
7.
Yorifuji, Tohru, Michiya Masue, & Hironori Nishibori. (2014). Congenital hyperinsulinism: Global and Japanese perspectives. Pediatrics International. 56(4). 467–476. 12 indexed citations
8.
Takahashi, Ikuko, Ken Higashimoto, Satoko Tsuchida, et al.. (2012). Congenital hyperinsulinism in an infant with paternal uniparental disomy on chromosome 11p15: Few clinical features suggestive of Beckwith-Wiedemann syndrome. Endocrine Journal. 60(4). 403–408. 14 indexed citations
9.
Yorifuji, Tohru, Rie Kawakita, Yuki Hosokawa, et al.. (2012). Efficacy and safety of long‐term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP‐channel hyperinsulinism. Clinical Endocrinology. 78(6). 891–897. 34 indexed citations
10.
Yorifuji, Tohru, Yuki Hosokawa, Rika Fujimaru, et al.. (2011). Lasting <sup>18</sup>F-DOPA PET Uptake after Clinical Remission of the Focal Form of Congenital Hyperinsulinism. Hormone Research in Paediatrics. 76(4). 286–290. 16 indexed citations
11.
Masue, Michiya, Hironori Nishibori, Seisuke Fukuyama, et al.. (2011). Diagnostic accuracy of [18F]-fluoro-l-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan. Clinical Endocrinology. 75(3). 342–346. 26 indexed citations
12.
Yorifuji, Tohru, Rie Kawakita, Hiraku Doi, et al.. (2010). Molecular and Clinical Analysis of Japanese Patients with Persistent Congenital Hyperinsulinism: Predominance of Paternally Inherited Monoallelic Mutations in the KATPChannel Genes. The Journal of Clinical Endocrinology & Metabolism. 96(1). E141–E145. 38 indexed citations
13.
Takahashi, Yukitoshi, et al.. (2002). Ictal and Interictal Single Photon Emission Computed Tomography in a Patient With Benign Familial Infantile Convulsions. Journal of Neuroimaging. 12(1). 75–77. 2 indexed citations
14.
Haneda, Noriyuki, et al.. (2001). Transcatheter closure of patent ductus arteriosus in an infant weighing 1180 g. Pediatrics International. 43(2). 176–178. 16 indexed citations
15.
Masuno, Mitsuo, Shunji Tomatsu, Yoshihiro Nakashima, et al.. (1993). Mucopolysaccharidosis IV A: Assignment of the Human N-Acetylgalactosamine-6-Sulfate Sulfatase (GALNS) Gene to Chromosome 16q24. Genomics. 16(3). 777–778. 45 indexed citations
16.
Fukuda, Seiji, Shunji Tomatsu, Michiya Masue, et al.. (1992). Mucopolysaccharidosis type IVA. N-acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases.. Journal of Clinical Investigation. 90(3). 1049–1053. 54 indexed citations
17.
Sukegawa, Kazuko, Shunji Tomatsu, Katsuyuki Tamai, et al.. (1992). Intermediate form of mucopolysaccharidosis type II (Hunter disease): A C1327 to T substitution in the iduronate sulfatase gene. Biochemical and Biophysical Research Communications. 183(2). 809–813. 26 indexed citations
18.
Tomatsu, Shunji, Seiji Fukuda, Michiya Masue, et al.. (1991). Morquio disease: Isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase. Biochemical and Biophysical Research Communications. 181(2). 677–683. 137 indexed citations
19.
Masue, Michiya, Kazuko Sukegawa, Tadao Orii, & Takashi Hashimoto. (1991). N-Acetylgalactosamine-6-Sulfate Sulfatase in Human Placenta: Purification and Characteristics1. The Journal of Biochemistry. 110(6). 965–970. 59 indexed citations
20.
Sukegawa, Kazuko, et al.. (1991). Purification and Partial Characterization of α-N-Acetylglucosaminidase from Human Liver1. The Journal of Biochemistry. 110(5). 842–846. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026